allografts
-
Biologics
Enovis™ and Ossium Health® Forge a Strategic Partnership to Expand the Distribution of OssiGraft™ and OssiGraft Prime™
A Strategic Partnership Set to Redefine Surgical Outcomes and Broaden Market Reach. WILMINGTON, DE, October 4, 2024 – Enovis™ (NYSE: ENOV),…
Read More » -
Biologics
Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds
BELGRADE, Mont., April 30, 2024 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Biologics
CTM Biomedical Announces New Partnerships with Pivot MedTech and TAG Medical to Improve Distribution of its Human Placental Connective Tissue Allografts to Orthopaedic Surgeons
MIAMI, March 8, 2023 /PRNewswire/ — CTM Biomedical, LLC, a leading US provider of human placental connective tissue allografts for surgical use,…
Read More » -
Biologics
AlloSource Celebrates 25 Years Of Doing More With Life
CENTENNIAL, Colo., Aug. 9, 2019 /PRNewswire/ — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, will…
Read More » -
Hospitals
Xtant Medical Receives FDA Clearance to Use Allografts in the Stand-Alone Irix-C™ Cervical Cage
BELGRADE, Mont., Nov. 15, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of…
Read More » -
Biologics
AlloSource Announces Two Innovative Bone Fiber Allografts
CENTENNIAL, Colo., June 13, 2016 /PRNewswire-USNewswire/ — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and…
Read More » -
MiMedx Is Issued Three New U.S. Patents For Placental Tissue Allografts
MARIETTA, Ga., June 11, 2013 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and…
Read More »